A round-up of developments in the pharmaceutical manufacturing sector, with facility updates from Neopharma, Nextpharma and Arch Pharmalab and new …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

